{"nctId":"NCT03455218","briefTitle":"Nitric Oxide Administration During Pediatric Cardiopulmonary Bypass Surgery to Prevent Platelet Activation","startDateStruct":{"date":"2018-04-25","type":"ACTUAL"},"conditions":["Inflammation","Platelet Dysfunction"],"count":40,"armGroups":[{"label":"Nitric Oxide","type":"EXPERIMENTAL","interventionNames":["Drug: Nitric Oxide","Device: INOmax"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: Placebo","Device: INOmax"]}],"interventions":[{"name":"Nitric Oxide","otherNames":["INOmax"]},{"name":"Placebo","otherNames":[]},{"name":"INOmax","otherNames":["inhaled nitric oxide delivery device"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Infants less than one year of age\n* Undergoing cardiac surgery with the use of cardiopulmonary bypass\n\nExclusion Criteria:\n\n* Prior surgery requiring CPB within the same hospitalization\n* Pre-operative need for extracorporeal membrane oxygenation or mechanical circulatory support\n* Known hypersensitivity to nitric oxide\n* Known hemostatic or thrombotic disorder that results in an altered transfusion/anticoagulation protocol","healthyVolunteers":false,"sex":"ALL","maximumAge":"1 Year","stdAges":["CHILD"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Change in Platelet Count","description":"Change in platelet count from baseline to conclusion of cardiopulmonary bypass = (Platelet count at end of CPB) - (Platelet count prior to start of CPB)","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"-221","spread":"107"},{"groupId":"OG001","value":"-242","spread":"114"}]}]}]},{"type":"PRIMARY","title":"30 Day Mortality","description":"30 day all cause mortality","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"PRIMARY","title":"Hospital Length of Stay","description":"Length of stay in the hospital following the operation","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8","spread":null},{"groupId":"OG001","value":"16.5","spread":null}]}]}]},{"type":"PRIMARY","title":"Methemoglobin Level Pre-CPB","description":"Methemoglobin levels in the blood measured at baseline","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0.77","spread":"0.42"},{"groupId":"OG001","value":"0.99","spread":"0.40"}]}]}]},{"type":"PRIMARY","title":"Methemoglobin Level-End of CPB","description":"Methemoglobin Level obtained at the end of cardiopulmonary bypass","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.56","spread":"0.43"},{"groupId":"OG001","value":"1.10","spread":"0.43"}]}]}]},{"type":"PRIMARY","title":"Methemoglobin Level-ICU Admit","description":"Methemoglobin level obtained at the time of ICU Admit","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.3","spread":"0.49"},{"groupId":"OG001","value":"1.08","spread":"0.29"}]}]}]},{"type":"SECONDARY","title":"Change in Platelet Response to TRAP as Measured by P-selectin Expression","description":"The P-selectin expression measured as a mean florescence was measured in platelets stimulated with thrombin receptor activating protein (TRAP) was measured at baseline and at conclusion of cardiopulmonary bypass. Mean of each assessment measured multiple times at each time point. Median change values were reported. The change in these values is the outcome measure = (Platelet response to TRAP at end of CPB) - (Platelet response to TRAP prior to CPB)","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"24","spread":null},{"groupId":"OG001","value":"30","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Platelet Response to U46619 as Measured by P-selectin Expression","description":"The P-selectin expression measured as a mean florescence was measured in platelets stimulated with U46619 was measured at baseline and at conclusion of cardiopulmonary bypass. Mean of each assessment measured multiple times at each time point. Median change values were reported. The change in these values is the outcome measure = (Platelet response to U46619 at end of CPB) - (Platelet response to U46619 prior to CPB)","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"51","spread":null},{"groupId":"OG001","value":"40","spread":null}]}]}]},{"type":"SECONDARY","title":"Change in Platelet Response to CRP as Measured by P-selectin Expression","description":"The P-selectin expression measured as a mean florescence was measured in platelets stimulated with CRP was measured at baseline and at conclusion of cardiopulmonary bypass. Mean of each assessment measured multiple times at each time point. Median change values were reported. The change in these values is the outcome measure = (Platelet response to CRP at end of CPB) - (Platelet response to CRP prior to CPB)","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"23","spread":null},{"groupId":"OG001","value":"23","spread":null}]}]}]},{"type":"SECONDARY","title":"Volume of Platelet Transfusion","description":"Volume per kg of platelet transfusion given to patient from the conclusion of cardiopulmonary bypass to 48 hours post-operatively","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null},{"groupId":"OG001","value":"9.8","spread":null}]}]}]},{"type":"SECONDARY","title":"Volume of Packed Red Blood Cell Transfusion","description":"Volume per kg of packed red blood cell transfusion given to patient from the conclusion of cardiopulmonary bypass to 48 hours post-operatively","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.1","spread":null},{"groupId":"OG001","value":"0","spread":null}]}]}]},{"type":"SECONDARY","title":"Transfusion Exposures","description":"Total number of transfusion exposures for a patient from the conclusion of cardiopulmonary bypass to 48 hours post-operatively","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2","spread":null},{"groupId":"OG001","value":"3","spread":null}]}]}]},{"type":"SECONDARY","title":"Length of Mechanical Ventilation","description":"Time (days) spent on ventilator following the operation","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"35.7","spread":null},{"groupId":"OG001","value":"28.2","spread":null}]}]}]},{"type":"SECONDARY","title":"Vasoactive Infusion Score","description":"Highest vasoactive infusion score (VIS) within 24 hours post-operatively. Vasoactive infusion score is based on the dose of the vasoactive infusions the patient is given VIS = Dopamine dose (μg/kg/min) + Dobutamine dose (μg/kg/min) +100 × epinephrine dose (μg/kg/min) + 10 X Milrinone dose (μg/kg/min) +10,000 × Vasopressin dose (U/kg/min) + 100 × Norepinephrine dose (μg/kg/min).\n\nThe minimum value is 0 if the patient is not on any vasoactive medications. There is no \"maximum\" score as there is no \"maximum\" dose of vasoactive medications. Higher scores indicate that the patient is on more vasoactive medications which is generally considered worse.","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9","spread":null},{"groupId":"OG001","value":"9.5","spread":null}]}]}]},{"type":"SECONDARY","title":"Number of Subjects Requiring Extracorporeal Membrane Oxygenation","description":"Dichotomous outcome-required extracorporeal membrane oxygenation within 48 hours post-operatively","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1","spread":null},{"groupId":"OG001","value":"1","spread":null}]}]}]},{"type":"SECONDARY","title":"Hospital Cost","description":"Total hospital cost at the time of discharge","paramType":"MEDIAN","dispersionType":"Inter-Quartile Range","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"137.7","spread":null},{"groupId":"OG001","value":"224.3","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":18},"commonTop":["Arrhythmia requiring temporary pacemaker","Sepsis","Chylothorax","Pulmonary hypertension","Seizure"]}}}